- Guidelines for alemtuzumab treatment in chronic lymphocytic leukemia (CLL)2012 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, First Faculty of Medicine
- Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge2016 | Faculty of Medicine in Hradec Králové
- Practical approach to management of chronic lymphocytic leukemia2016 | Faculty of Medicine in Hradec Králové
- Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study2015 | First Faculty of Medicine, Third Faculty of Medicine
- Ofatumumab2011 | Faculty of Medicine in Hradec Králové
- Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia2016 | Faculty of Medicine in Hradec Králové
- Incidence and prognostic significance of serum immunoglobulins and paraproteins in patients with chronic lymphocytic leukaemia: another valuable piece of the puzzle2020 | Faculty of Medicine in Hradec Králové
- Chemotherapy, radiotherapy and surgery in chronic lymphocytic leukemia treatment2010 | Third Faculty of Medicine
- Treatment of elderly and comorbid patients with chronic lymphocytic leukemia2017 | Faculty of Medicine in Hradec Králové
- Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia2023 | Faculty of Medicine in Hradec Králové
- Therapy of elderly/comorbid patients with chronic lymphocytic leukemia2013 | Faculty of Medicine in Hradec Králové
- Targeted treatment for chronic lymphocytic leukemia: clinical potential of obinutuzumab2014 | Faculty of Medicine in Hradec Králové
- Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients2015 | Publication without faculty affiliation
- Idelalisib in the treatment of chronic lymphocytic leukaemia2015 | First Faculty of Medicine
- Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients2015 | Faculty of Medicine in Hradec Králové
- Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study2015 | Faculty of Medicine in Hradec Králové
- Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions2016 | Faculty of Medicine in Hradec Králové
- Single-agent ibrutinib in RESONATE-2TM and RESONATETM versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia2019 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Modern approach to the treatment of chronic lymphocytic leukemia2023 | Faculty of Medicine in Hradec Králové
- Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia2010 | First Faculty of Medicine, Third Faculty of Medicine